New Treatment for Liver Disease
Primary biliary cirrhosis, or PBC is a slow acting liver disease that can lead to scarring and the need for a liver transplant. PBC affects 10 times as many women than men and is not related to drinking alcohol. While there is no cure, a promising new ...
WTAJ - Mon, 08 Dec 2014 11:41

The 2015 Calendar Of NASH Trial Catalysts III: Galmed And Intercept
OCA also significantly reduced ALT, aspartate aminotransferase (AST, another liver enzyme that is elevated in hepatic disease), and γ-glutamyl transpeptidase (an indicator of bile blockage). However, the number of patients whose NASH resolved did not ...
Seeking Alpha - Fri, 19 Dec 2014 09:25



Daughter gives mother new life with rare live donor liver transplant
SALT LAKE CITY — When the Garcia family found out that Rachel Garcia-Trujillo could be a live liver donor for her mother, Betty Garcia, they were elated. Garcia had been suffering from primary biliary cirrhosis for 16 years. She took a turn for the ...
KSL.com - Tue, 16 Dec 2014 16:26

Rare live liver from daughter gives mother new life
Deseret News - Tue, 16 Dec 2014 14:07



UT Southwestern Doctors Help Mother of 3 Get Liver Transplant
The ultimate result, which changed Michelle Linss' life, was a diagnosis of primary biliary cirrhosis (PBC), a disease wherein the bile ducts are obstructed and damaged, causing a harmful accumulation of bile in the liver. The disease progresses quite ...
BioNews Texas - Wed, 26 Nov 2014 12:48



Tatamy family writes to Santa pleading for a new liver for nine-month-old baby boy
According to the American Liver Foundation, biliary atresia is a disease that affects an infant's bile ducts. A blockage doesn't allow bile to exit the liver the way it's supposed to, and it can result in cirrhosis or scarring of the liver, according ...
lehighvalleylive.com - Fri, 12 Dec 2014 09:00

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Resumed with Buy at Janney on ...
Coverage of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) has been resumed by analysts at Janney Capital with a buy rating on the potential of pipeline product Obeticholic acid (OCA) to treat liver diseases primary biliary cirrhosis (PBC) mon-alcoholic ...
Street Report - Thu, 18 Dec 2014 05:18

Experts provide recommendations for combating liver disease in UK
Liver disease is the third most common cause of premature death in the United Kingdom, with mortality rates increasing by 400% since 1970. In a new report, Roger Williams, MD, director of the Institute of Hepatology in London, and colleagues provide ...
Healio - Thu, 04 Dec 2014 09:22

Low ALP, bilirubin levels increased transplant-free survival rate in PBC patients
Hansen and colleagues from the Global Primary Biliary Cirrhosis (PBC) Study Group, a collaboration between 15 liver centers throughout the United States and Europe, analyzed data of 4,845 patients with PBC from long-term follow-up cohorts. A majority ...
Healio - Wed, 10 Dec 2014 06:26


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014